De Vleeschauwer Stéphanie, Lambaerts Kathleen, Hernot Sophie, Debusschere Karlijn
Laboratory Animal Center, KU Leuven, 3000 Leuven, Belgium.
Laboratory for In Vivo Cellular and Molecular Imaging (ICMI-MIMA/BEFY), Vrije Universiteit Brussel, 1090 Brussels, Belgium.
Animals (Basel). 2023 Aug 10;13(16):2581. doi: 10.3390/ani13162581.
According to the EU Directive 2010/63, all animal procedures must be classified as non-recovery, mild, moderate or severe. Several examples are included in the Directive to help in severity classification. Since the implementation of the Directive, different publications and guidelines have been disseminated on the topic. However, due to the large variety of disease models and animal procedures carried out in many different animal species, guidance on the severity classification of specific procedures or models is often lacking or not specific enough. The latter is especially the case in disease models where the level of pain, suffering, distress and lasting harm depends on the duration of the study (for progressive disease models) or the dosage given (for infectious or chemically induced disease models). This, in turn, may lead to inconsistencies in severity classification between countries, within countries and even within institutions. To overcome this, two Belgian academic institutions with a focus on biomedical research collaborated to develop a severity classification for all the procedures performed. This work started with listing all in-house procedures and assigning them to 16 (sub)categories. First, we determined which parameters, such as clinical signs, dosage or duration, were crucial for severity classification within a specific (sub)category. Next, a severity classification was assigned to the different procedures, which was based on professional judgment by the designated veterinarians, members of the animal welfare body (AWB) and institutional animal ethics committee (AEC), integrating the available literature and guidelines. During the classification process, the use of vague terminology, such as 'minor impact', was avoided as much as possible. Instead, well-defined cut-offs between severity levels were used. Furthermore, we sought to define common denominators to group procedures and to be able to classify new procedures more easily. Although the primary aim is to address prospective severity, this can also be used to assess actual severity. In summary, we developed a severity classification for all procedures performed in two academic, biomedical institutions. These include many procedures and disease models in a variety of animal species for which a severity classification was not reported so far, or the terms that assign them to a different severity were too vague.
根据欧盟指令2010/63,所有动物实验程序必须被归类为不可恢复、轻度、中度或重度。该指令中包含了几个示例以帮助进行严重程度分类。自该指令实施以来,关于这一主题的不同出版物和指南已经发布。然而,由于在许多不同动物物种中进行的疾病模型和动物实验程序种类繁多,对于特定程序或模型的严重程度分类指导往往缺乏或不够具体。在疾病模型中尤其如此,其中疼痛、痛苦、不适和持久伤害的程度取决于研究持续时间(对于进行性疾病模型)或给予的剂量(对于感染性或化学诱导性疾病模型)。这反过来可能导致各国之间、国家内部甚至机构内部在严重程度分类上的不一致。为了克服这一问题,比利时两所专注于生物医学研究的学术机构合作,为所进行的所有程序制定了严重程度分类。这项工作首先列出所有内部程序,并将它们分配到16个(子)类别中。首先,我们确定哪些参数,如临床症状、剂量或持续时间,对于特定(子)类别内的严重程度分类至关重要。接下来,根据指定兽医、动物福利机构(AWB)成员和机构动物伦理委员会(AEC)的专业判断,结合现有文献和指南,为不同程序分配严重程度分类。在分类过程中,尽可能避免使用模糊术语,如“轻微影响”。相反,使用了明确界定的严重程度级别之间的界限。此外,我们试图定义共同标准来对程序进行分组,并能够更轻松地对新程序进行分类。虽然主要目的是解决预期的严重程度,但这也可用于评估实际严重程度。总之,我们为两所学术性生物医学机构所进行的所有程序制定了严重程度分类。这些程序包括多种动物物种中的许多程序和疾病模型,到目前为止尚未报告其严重程度分类,或者将它们归为不同严重程度的术语过于模糊。